This interim guidance document aims to help clinicians with supportive management of patients who have acute respiratory failure and septic shock as a consequence of severe infection. Because other complications have been seen (renal failure, pericarditis, DIC, as above) clinicians should monitor for the...
¿Qué circunstancias o hallazgos clínicos (síntomas y signos) deben hacer que un profesional de la salud sospeche la tos ferina? Tomando en cuenta las características del paciente y de la enfermedad (fase clínica, severidad), ¿cuáles procedimientos o pruebas deben emplearse para diagnosticar (conf...
Generar recomendaciones basadas en la evidencia para la detección temprana de cáncer de pulmón en población de alto riesgo de desarrollar cáncer en Colombia.
Generar recomendaciones basadas en la evidencia para el diagnóstico, estadificación, evaluación
preoperatoriay tratamiento en pacientes con...
Brindar parámetros de práctica clínica, basados en la mejor evidencia disponible para la atención en salud y utilización racional de recursos para la prevención, detección temprana, diagnóstico, tratamiento y seguimiento de las dislipidemias en la población mayor de 18 años. Generar cambios en ...
"DESCRIPTION:
The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the treatment of anemia and iron deficiency in adult patients with heart disease.
METHODS:
This guideline is based on published literature in the English langua...
Hematínicos,
Ferro/efeitos adversos,
Anemia Ferropriva,
Doença das Coronárias,
Insuficiência Cardíaca,
Anemia Ferropriva/complicações,
Anemia Ferropriva/terapia,
Doença das Coronárias/complicações,
Doença das Coronárias/mortalidade,
Hematínicos/efeitos adversos,
Hematínicos/uso terapêutico,
Ferro/uso terapêutico
"OBJECTIVE:
The aim was to formulate practice guidelines for the diagnosis and treatment of polycystic ovary syndrome (PCOS).
PARTICIPANTS:
An Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer developed the guideline.
EVIDENCE:
This evidence-based guideline was de...
Fator de Necrose Tumoral alfa,
Mercaptopurina,
Azatioprina,
Metotrexato,
Doença de Crohn,
Gastroenterologia,
Mercaptopurina/uso terapêutico,
Metotrexato/uso terapêutico,
Indução de Remissão,
Doença de Crohn/tratamento farmacológico,
Fator de Necrose Tumoral alfa/antagonistas & inibidores
Kantor, PF;
Lougheed, J;
Dancea, A;
McGillion, M;
Barbosa, N;
Chan, C;
Dillenburg, R;
Atallah, J;
Buchholz, H;
Chant-Gambacort, C;
Conway, J;
Gardin, L;
George, K;
Greenway, S;
Human, DG;
Jeewa, A;
Price, JF;
Ross, RD;
Roche, SL;
Ryerson, L;
Soni, R;
Wilson, J;
Wong, K.
Pediatric heart failure (HF) is an important cause of morbidity and mortality in childhood. This article presents guidelines for the recognition, diagnosis, and early medical management of HF in infancy, childhood, and adolescence. The guidelines are intended to assist practitioners in office-based or em...
Bloqueadores do Receptor Tipo 1 de Angiotensina II/uso terapêutico,
Inibidores da Enzima Conversora de Angiotensina,
Biomarcadores/sangue,
Cardiotônicos,
Catecolaminas/uso terapêutico,
Diuréticos,
Vasodilatadores,
Vasopressinas,
Cardiopatias Congênitas,
Morte Súbita Cardíaca/etiologia,
Insuficiência Cardíaca,
Miocardite,
Ecocardiografia,
Eletrocardiografia Ambulatorial,
Algoritmos,
Cardiopatias Congênitas/diagnóstico,
Cardiopatias Congênitas/terapia,
Miocárdio/patologia,
Morte Súbita Cardíaca/prevenção & controle
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. METHODS: This guideline is based on a systematic evidence review eval...
Insuficiência Renal Crônica/diagnóstico,
Insuficiência Renal Crônica/tratamento farmacológico,
Progressão da Doença,
Triagem,
Antagonistas de Receptores de Angiotensina/uso terapêutico,
Inibidores da Enzima Conversora de Angiotensina/uso terapêutico,
Anti-Hipertensivos/uso terapêutico,
Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico,
Hipolipemiantes/uso terapêutico,
Genfibrozila/uso terapêutico,
Doenças Assintomáticas,
Quimioterapia Combinada,
Abordagem GRADE
